AHMED ELKHANANY to Antineoplastic Agents, Hormonal
This is a "connection" page, showing publications AHMED ELKHANANY has written about Antineoplastic Agents, Hormonal.
Connection Strength
0.212
-
CDK4/6 inhibitors plus endocrine therapy versus endocrine monotherapy in hormone receptor-positive, HER2-negative advanced breast cancer: a reconstructed individual patient data meta-analysis of phase 3 randomised controlled trials. Lancet Oncol. 2026 May; 27(5):592-603.
Score: 0.212